- Home
- USNA vs OLMA Comparison
USNA vs OLMA Comparison
Compare USNA & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- OLMA
- Stock Information
- Founded
- USNA 1992
- OLMA 2006
- Country
- USNA United States
- OLMA United States
- Employees
- USNA N/A
- OLMA N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- OLMA Health Care
- Exchange
- USNA Nasdaq
- OLMA Nasdaq
- Market Cap
- USNA 565.5M
- OLMA 560.7M
- IPO Year
- USNA 1996
- OLMA 2020
- Fundamental
- Price
- USNA $26.46
- OLMA $10.25
- Analyst Decision
- USNA Hold
- OLMA Strong Buy
- Analyst Count
- USNA 1
- OLMA 5
- Target Price
- USNA $36.00
- OLMA $24.00
- AVG Volume (30 Days)
- USNA 136.2K
- OLMA 1.2M
- Earning Date
- USNA 10-21-2025
- OLMA 11-11-2025
- Dividend Yield
- USNA N/A
- OLMA N/A
- EPS Growth
- USNA N/A
- OLMA N/A
- EPS
- USNA 1.80
- OLMA N/A
- Revenue
- USNA $899,221,000.00
- OLMA N/A
- Revenue This Year
- USNA $13.94
- OLMA N/A
- Revenue Next Year
- USNA $7.95
- OLMA N/A
- P/E Ratio
- USNA $14.84
- OLMA N/A
- Revenue Growth
- USNA 2.75
- OLMA N/A
- 52 Week Low
- USNA $23.10
- OLMA $2.86
- 52 Week High
- USNA $41.84
- OLMA $13.51
- Technical
- Relative Strength Index (RSI)
- USNA 27.82
- OLMA 67.45
- Support Level
- USNA $26.88
- OLMA $8.01
- Resistance Level
- USNA $27.95
- OLMA $11.54
- Average True Range (ATR)
- USNA 0.74
- OLMA 0.79
- MACD
- USNA -0.27
- OLMA 0.13
- Stochastic Oscillator
- USNA 3.47
- OLMA 67.46
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.